Opioid Use Disorder and the COVID 19 Pandemic: A Call to Sustain Regulatory Easements and Further Expand Access to Treatment

Substance Abuse - Tập 41 Số 2 - Trang 147-149 - 2020
Traci C. Green1,2, Jeffrey Bratberg3, Deborah S. Finnell4
1Department of Emergency Medicine and Epidemiology, The Warren Alpert School of Medicine of Brown University, Rhode Island Hospital, Providence, Rhode Island, USA;
2Opioid Policy Research Collaborative, Institute for Behavioral Health at The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachussetts, USA;
3University of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA
4Johns Hopkins School of Nursing, Baltimore, Maryland, USA

Tóm tắt

We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMp1803982

10.1001/jamapsychiatry.2018.3685

GovTrack. Summary of H.R. 2482: Mainstreaming Addiction Treatment Act of 2019. GovTrack.us; 2020. https://www.govtrack.us/congress/bills/116/hr2482/summary. Accessed February 7, 2020.

10.1016/j.drugpo.2019.07.006

10.17226/25626

MARA International.™ Medication-Assisted Recovery Anonymous; 2020. https://www.mara-international.org/. Accessed March 26, 2020.

10.3109/10826084.2015.978675

10.1007/s11524-014-9904-5

10.1176/appi.ps.2012000p7

Elflein J, Number of pharmacists in the U.S. from 2001 to 2016. Statista; 2018. https://www.statista.com/statistics/185723/number-of-pharmacists-in-the-us-since-2001/. Accessed March 22, 2020.

Green TC, 2020, Sub Abuse, 11, 1, 10.2147/SAR.S228224

American Pharmacists Association. Increasing access to and advocacy for medications for opioid use disorder; 2020. https://www.pharmacist.com/sites/default/files/audience/NBI%20%2308%20-%20Medications%20for%20Opioid%20Use%20Disorder%20. (MOUD)-FINAL_0.pdf. Accessed March 26, 2020.

Substance Abuse and Mental Health Services Administration. FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency; 2020. https://www.samhsa.gov/sites/default/files/faqs-for-oud-prescribing-and-dispensing.pdf. Accessed March 22, 2020.

10.1016/j.sapharm.2017.12.009

10.1007/s11606-018-4801-3

10.1136/bmj.c4851

Levander XA, Wakeman SE. Covid-19 will worsen the opioid overdose crisis is we don't prepare now. STAT; 2020. https://www.statnews.com/2020/03/17/covid-19-will-worsen-the-opioid-overdose-crisis-if-we-dont-prepare-now/. Accessed March 26, 2020.

10.1080/08897077.2018.1543382

10.1080/08897077.2015.1101733

10.1016/j.outlook.2017.07.001

10.1377/hlthaff.2019.00859

10.1016/j.ypmed.2019.105780

Thông tin
Thông tin xuất bản

Substance Abuse

Tập 41 Số 2

147-149

Thông tin tác giả